| Announce Date | 11/24/2025 |
| EPS Normalized Actual | $1.32 (Beat by $0.905) |
| EPS GAAP Actual | $1.32 (Beat by $0.905) |
| Revenue Actual | $0.09757B |
| Revenue Surprise | Beat by $97.57M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.69 |
| EPS GAAP Estimate | $0.69 |
| Revenue Estimate | $0.091B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Dec 2025 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.33 | 0.98 | 0.09757B | -13.42% | -2.43M |
| FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 0.097514B | -11.78% | -13.79M |
| FQ1 2025 (Mar 2025) | 0.78 | 0.78 | 0.097B | -10.31% | 3M |
| FQ2 2025 (Jun 2025) | 0.92 | 0.58 | 0.119911B | 11.75% | 22.91M |
| FQ3 2024 (Sep 2024) | 0.79 | 0.756667 | 0.110664B | -9.61% | 4.96M |
| FQ2 2024 (Jun 2024) | 8.1 | 8.1 | 0.105824B | -8.54% | 2.12M |
| FQ1 2024 (Mar 2024) | -0.0051 | -0.0051 | 0.107B | -11.47% | 107M |
| FQ4 2023 (Dec 2023) | 0.0557 | 0.0557 | 0.109B | 100% | -7M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.69
Consensus Revenue Estimates
0.091B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 1.15 | -- | 1.12439 | 1.17561 | 1 |
| FQ3 2026 (Sep 2026) | 1.4 | 5 | 1.36882 | 1.43118 | 1 |
| FQ2 2026 (Jun 2026) | 1.18 | 22.03 | 1.15372 | 1.20628 | 1 |
| FQ1 2026 (Mar 2026) | 0.69 | -13.04 | 0.67463 | 0.70537 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.11B | -- | 0.11B | 0.12B | 1 |
| FQ3 2026 (Sep 2026) | 0.12B | 17.52 | 0.12B | 0.12B | 1 |
| FQ2 2026 (Jun 2026) | 0.11B | -9.61 | 0.11B | 0.11B | 1 |
| FQ1 2026 (Mar 2026) | 0.09B | -6.59 | 0.09B | 0.09B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.35 | 1.33 | 0.98 | 73.68% |
| FQ4 2024 (Dec 2024) | 0 | -0.13 | -0.13 | 100% |
| FQ1 2025 (Mar 2025) | 0 | 0.78 | 0.78 | 100% |
| FQ2 2025 (Jun 2025) | 0.34 | 0.92 | 0.58 | 63.04% |
| FQ3 2024 (Sep 2024) | 0.033333 | 0.79 | 0.756667 | 95.78% |
| FQ2 2024 (Jun 2024) | 0 | 8.1 | 8.1 | 100% |
| FQ1 2024 (Mar 2024) | -0.0051 | -0.0051 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0.0557 | 0.0557 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.1B | $0.1B | $-2.43M | -2.49% |
| FQ4 2024 (Dec 2024) | $0.11B | $0.1B | $-13.79M | -14.14% |
| FQ1 2025 (Mar 2025) | $0.09B | $0.1B | $3M | 3.09% |
| FQ2 2025 (Jun 2025) | $0.1B | $0.12B | $22.91M | 19.11% |
| FQ3 2024 (Sep 2024) | $0.11B | $0.11B | $4.96M | 4.49% |
| FQ2 2024 (Jun 2024) | $0.1B | $0.11B | $2.12M | 2.01% |
| FQ1 2024 (Mar 2024) | $0B | $0.11B | $107M | 100% |
| FQ4 2023 (Dec 2023) | $0.12B | $0.11B | $-7M | -6.42% |